世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

OTCペット薬の世界市場インサイト、2028年までの予測


Global OTC Pet Medication Market Insights, Forecast to 2028

ペットの飼育数の増加や、ペットの病気や健康に対する意識の高まりが、ペット用OTC薬の需要を促進しています。OTCペット薬市場では、企業はドラッグストアや薬局、ペット専門店など、さまざまな販売チャネルを通... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年3月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ペットの飼育数の増加や、ペットの病気や健康に対する意識の高まりが、ペット用OTC薬の需要を促進しています。OTCペット薬市場では、企業はドラッグストアや薬局、ペット専門店など、さまざまな販売チャネルを通じて競争力のある価格でペット薬を提供しています。また、OTCペット用医薬品はオンラインプラットフォームでも販売されており、OTCペット用医薬品市場にとって有利な販売チャネルとなっています。

市場の分析と洞察。OTCペット用医薬品の世界市場
OTCペット薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率は%になると予想されています。
この健康危機による経済変化を十分に考慮し、2021年にOTCペット薬世界市場の%を占めたノミ・ダニ除去は、2028年には100万米ドルの価値を持ち、COVID-19後の期間に修正された%のCAGRで成長すると予測されています。一方、犬&猫セグメントは、この予測期間を通して%CAGRに変更されています。

中国のOTCペット薬の市場規模は2021年に100万米ドル、北米と欧州のOTCペット薬の市場規模はそれぞれ100万米ドル、100万米ドルとされています。北米の割合は2021年に%、中国と欧州はそれぞれ%と%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%であった。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパのOTC Pet Medicationの展望としては、ドイツが2028年までに100万米ドルに達すると予測され、予測期間を通じてCAGR %を推移しています。

本レポートは、業界標準の分析精度と高いデータ整合性により、世界のOTCペット薬市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みを行っています。本レポートの購入者は、OTCペット用医薬品の世界市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートはプレイヤーが競合他社に対する競争力を獲得し、OTCペット用医薬品の世界市場での成功を持続させるために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、OTCペット用医薬品の世界市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界のOTCペット用医薬品の範囲と市場規模
OTCペット薬市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されています。OTCペット薬の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことが可能となります。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
ノミ・ダニ駆除
ペインリリーフ&関節炎
駆虫剤
その他
用途別セグメント
犬・猫
鳥類
魚類・爬虫類
その他

会社別
バイエル コンパニオンアニマル
ベーリンガーインゲルハイム アニマルヘルス社
セバ サンテ アニマル
メルク株式会社
ゾエティス社
エランコ
Virbac SA
ベトキノールSA
フロントライン
ザイモックス
クロラセブ
スルホックス
アデカン
デクラ・ファーマシューティカルズPLC
ニュートラマックス・ラボラトリーズ, Inc.

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Pet Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fleas & Ticks Removal
1.2.3 Pain Relief & Arthritis
1.2.4 Dewormers
1.2.5 Others
1.3 Market by Application
1.3.1 Global OTC Pet Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dogs & Cats
1.3.3 Birds
1.3.4 Fish & Reptiles
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Pet Medication Market Perspective (2017-2028)
2.2 OTC Pet Medication Growth Trends by Region
2.2.1 OTC Pet Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Pet Medication Historic Market Size by Region (2017-2022)
2.2.3 OTC Pet Medication Forecasted Market Size by Region (2023-2028)
2.3 OTC Pet Medication Market Dynamics
2.3.1 OTC Pet Medication Industry Trends
2.3.2 OTC Pet Medication Market Drivers
2.3.3 OTC Pet Medication Market Challenges
2.3.4 OTC Pet Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Pet Medication Players by Revenue
3.1.1 Global Top OTC Pet Medication Players by Revenue (2017-2022)
3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2017-2022)
3.2 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Pet Medication Revenue
3.4 Global OTC Pet Medication Market Concentration Ratio
3.4.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2021
3.5 OTC Pet Medication Key Players Head office and Area Served
3.6 Key Players OTC Pet Medication Product Solution and Service
3.7 Date of Enter into OTC Pet Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Pet Medication Breakdown Data by Type
4.1 Global OTC Pet Medication Historic Market Size by Type (2017-2022)
4.2 Global OTC Pet Medication Forecasted Market Size by Type (2023-2028)
5 OTC Pet Medication Breakdown Data by Application
5.1 Global OTC Pet Medication Historic Market Size by Application (2017-2022)
5.2 Global OTC Pet Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Pet Medication Market Size (2017-2028)
6.2 North America OTC Pet Medication Market Size by Type
6.2.1 North America OTC Pet Medication Market Size by Type (2017-2022)
6.2.2 North America OTC Pet Medication Market Size by Type (2023-2028)
6.2.3 North America OTC Pet Medication Market Share by Type (2017-2028)
6.3 North America OTC Pet Medication Market Size by Application
6.3.1 North America OTC Pet Medication Market Size by Application (2017-2022)
6.3.2 North America OTC Pet Medication Market Size by Application (2023-2028)
6.3.3 North America OTC Pet Medication Market Share by Application (2017-2028)
6.4 North America OTC Pet Medication Market Size by Country
6.4.1 North America OTC Pet Medication Market Size by Country (2017-2022)
6.4.2 North America OTC Pet Medication Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe OTC Pet Medication Market Size (2017-2028)
7.2 Europe OTC Pet Medication Market Size by Type
7.2.1 Europe OTC Pet Medication Market Size by Type (2017-2022)
7.2.2 Europe OTC Pet Medication Market Size by Type (2023-2028)
7.2.3 Europe OTC Pet Medication Market Share by Type (2017-2028)
7.3 Europe OTC Pet Medication Market Size by Application
7.3.1 Europe OTC Pet Medication Market Size by Application (2017-2022)
7.3.2 Europe OTC Pet Medication Market Size by Application (2023-2028)
7.3.3 Europe OTC Pet Medication Market Share by Application (2017-2028)
7.4 Europe OTC Pet Medication Market Size by Country
7.4.1 Europe OTC Pet Medication Market Size by Country (2017-2022)
7.4.2 Europe OTC Pet Medication Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Pet Medication Market Size (2017-2028)
8.2 Asia-Pacific OTC Pet Medication Market Size by Type
8.2.1 Asia-Pacific OTC Pet Medication Market Size by Type (2017-2022)
8.2.2 Asia-Pacific OTC Pet Medication Market Size by Type (2023-2028)
8.2.3 Asia-Pacific OTC Pet Medication Market Share by Type (2017-2028)
8.3 Asia-Pacific OTC Pet Medication Market Size by Application
8.3.1 Asia-Pacific OTC Pet Medication Market Size by Application (2017-2022)
8.3.2 Asia-Pacific OTC Pet Medication Market Size by Application (2023-2028)
8.3.3 Asia-Pacific OTC Pet Medication Market Share by Application (2017-2028)
8.4 Asia-Pacific OTC Pet Medication Market Size by Region
8.4.1 Asia-Pacific OTC Pet Medication Market Size by Region (2017-2022)
8.4.2 Asia-Pacific OTC Pet Medication Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Pet Medication Market Size (2017-2028)
9.2 Latin America OTC Pet Medication Market Size by Type
9.2.1 Latin America OTC Pet Medication Market Size by Type (2017-2022)
9.2.2 Latin America OTC Pet Medication Market Size by Type (2023-2028)
9.2.3 Latin America OTC Pet Medication Market Share by Type (2017-2028)
9.3 Latin America OTC Pet Medication Market Size by Application
9.3.1 Latin America OTC Pet Medication Market Size by Application (2017-2022)
9.3.2 Latin America OTC Pet Medication Market Size by Application (2023-2028)
9.3.3 Latin America OTC Pet Medication Market Share by Application (2017-2028)
9.4 Latin America OTC Pet Medication Market Size by Country
9.4.1 Latin America OTC Pet Medication Market Size by Country (2017-2022)
9.4.2 Latin America OTC Pet Medication Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Pet Medication Market Size (2017-2028)
10.2 Middle East & Africa OTC Pet Medication Market Size by Type
10.2.1 Middle East & Africa OTC Pet Medication Market Size by Type (2017-2022)
10.2.2 Middle East & Africa OTC Pet Medication Market Size by Type (2023-2028)
10.2.3 Middle East & Africa OTC Pet Medication Market Share by Type (2017-2028)
10.3 Middle East & Africa OTC Pet Medication Market Size by Application
10.3.1 Middle East & Africa OTC Pet Medication Market Size by Application (2017-2022)
10.3.2 Middle East & Africa OTC Pet Medication Market Size by Application (2023-2028)
10.3.3 Middle East & Africa OTC Pet Medication Market Share by Application (2017-2028)
10.4 Middle East & Africa OTC Pet Medication Market Size by Country
10.4.1 Middle East & Africa OTC Pet Medication Market Size by Country (2017-2022)
10.4.2 Middle East & Africa OTC Pet Medication Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer Companion Animal
11.1.1 Bayer Companion Animal Company Details
11.1.2 Bayer Companion Animal Business Overview
11.1.3 Bayer Companion Animal OTC Pet Medication Introduction
11.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2017-2022)
11.1.5 Bayer Companion Animal Recent Developments
11.2 Boehringer Ingelheim Animal Health
11.2.1 Boehringer Ingelheim Animal Health Company Details
11.2.2 Boehringer Ingelheim Animal Health Business Overview
11.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
11.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2017-2022)
11.2.5 Boehringer Ingelheim Animal Health Recent Developments
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale OTC Pet Medication Introduction
11.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2017-2022)
11.3.5 Ceva Sante Animale Recent Developments
11.4 Merck Inc.
11.4.1 Merck Inc. Company Details
11.4.2 Merck Inc. Business Overview
11.4.3 Merck Inc. OTC Pet Medication Introduction
11.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.4.5 Merck Inc. Recent Developments
11.5 Zoetis Inc.
11.5.1 Zoetis Inc. Company Details
11.5.2 Zoetis Inc. Business Overview
11.5.3 Zoetis Inc. OTC Pet Medication Introduction
11.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.5.5 Zoetis Inc. Recent Developments
11.6 Elanco
11.6.1 Elanco Company Details
11.6.2 Elanco Business Overview
11.6.3 Elanco OTC Pet Medication Introduction
11.6.4 Elanco Revenue in OTC Pet Medication Business (2017-2022)
11.6.5 Elanco Recent Developments
11.7 Virbac SA
11.7.1 Virbac SA Company Details
11.7.2 Virbac SA Business Overview
11.7.3 Virbac SA OTC Pet Medication Introduction
11.7.4 Virbac SA Revenue in OTC Pet Medication Business (2017-2022)
11.7.5 Virbac SA Recent Developments
11.8 Vetoquinol SA
11.8.1 Vetoquinol SA Company Details
11.8.2 Vetoquinol SA Business Overview
11.8.3 Vetoquinol SA OTC Pet Medication Introduction
11.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2017-2022)
11.8.5 Vetoquinol SA Recent Developments
11.9 Frontline
11.9.1 Frontline Company Details
11.9.2 Frontline Business Overview
11.9.3 Frontline OTC Pet Medication Introduction
11.9.4 Frontline Revenue in OTC Pet Medication Business (2017-2022)
11.9.5 Frontline Recent Developments
11.10 Zymox
11.10.1 Zymox Company Details
11.10.2 Zymox Business Overview
11.10.3 Zymox OTC Pet Medication Introduction
11.10.4 Zymox Revenue in OTC Pet Medication Business (2017-2022)
11.10.5 Zymox Recent Developments
11.11 ChloraSeb
11.11.1 ChloraSeb Company Details
11.11.2 ChloraSeb Business Overview
11.11.3 ChloraSeb OTC Pet Medication Introduction
11.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2017-2022)
11.11.5 ChloraSeb Recent Developments
11.12 Sulfox
11.12.1 Sulfox Company Details
11.12.2 Sulfox Business Overview
11.12.3 Sulfox OTC Pet Medication Introduction
11.12.4 Sulfox Revenue in OTC Pet Medication Business (2017-2022)
11.12.5 Sulfox Recent Developments
11.13 Adequan
11.13.1 Adequan Company Details
11.13.2 Adequan Business Overview
11.13.3 Adequan OTC Pet Medication Introduction
11.13.4 Adequan Revenue in OTC Pet Medication Business (2017-2022)
11.13.5 Adequan Recent Developments
11.14 Dechra Pharmaceuticals PLC
11.14.1 Dechra Pharmaceuticals PLC Company Details
11.14.2 Dechra Pharmaceuticals PLC Business Overview
11.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
11.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2017-2022)
11.14.5 Dechra Pharmaceuticals PLC Recent Developments
11.15 Nutramax Laboratories, Inc.
11.15.1 Nutramax Laboratories, Inc. Company Details
11.15.2 Nutramax Laboratories, Inc. Business Overview
11.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
11.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.15.5 Nutramax Laboratories, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Increasing pet ownership and awareness related to pet diseases or pet health have fuelled the demand for OTC pet medication. In the OTC pet medication market, companies are offering pet medicines at competitive prices through various sales channels such as drug & pharmacy stores, pet specialty stores, etc. OTC pet medications are also available through online platforms, which has become a lucrative sales channel for the OTC pet medication market.

Market Analysis and Insights: Global OTC Pet Medication Market
The global OTC Pet Medication market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Fleas & Ticks Removal accounting for % of the OTC Pet Medication global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dogs & Cats segment is altered to an % CAGR throughout this forecast period.

China OTC Pet Medication market size is valued at US$ million in 2021, while the North America and Europe OTC Pet Medication are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe OTC Pet Medication landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Pet Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Pet Medication market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Pet Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Pet Medication market.

Global OTC Pet Medication Scope and Market Size
OTC Pet Medication market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global OTC Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Segment by Application
Dogs & Cats
Birds
Fish & Reptiles
Others

By Company
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Pet Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fleas & Ticks Removal
1.2.3 Pain Relief & Arthritis
1.2.4 Dewormers
1.2.5 Others
1.3 Market by Application
1.3.1 Global OTC Pet Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dogs & Cats
1.3.3 Birds
1.3.4 Fish & Reptiles
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Pet Medication Market Perspective (2017-2028)
2.2 OTC Pet Medication Growth Trends by Region
2.2.1 OTC Pet Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Pet Medication Historic Market Size by Region (2017-2022)
2.2.3 OTC Pet Medication Forecasted Market Size by Region (2023-2028)
2.3 OTC Pet Medication Market Dynamics
2.3.1 OTC Pet Medication Industry Trends
2.3.2 OTC Pet Medication Market Drivers
2.3.3 OTC Pet Medication Market Challenges
2.3.4 OTC Pet Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Pet Medication Players by Revenue
3.1.1 Global Top OTC Pet Medication Players by Revenue (2017-2022)
3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2017-2022)
3.2 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Pet Medication Revenue
3.4 Global OTC Pet Medication Market Concentration Ratio
3.4.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2021
3.5 OTC Pet Medication Key Players Head office and Area Served
3.6 Key Players OTC Pet Medication Product Solution and Service
3.7 Date of Enter into OTC Pet Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Pet Medication Breakdown Data by Type
4.1 Global OTC Pet Medication Historic Market Size by Type (2017-2022)
4.2 Global OTC Pet Medication Forecasted Market Size by Type (2023-2028)
5 OTC Pet Medication Breakdown Data by Application
5.1 Global OTC Pet Medication Historic Market Size by Application (2017-2022)
5.2 Global OTC Pet Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Pet Medication Market Size (2017-2028)
6.2 North America OTC Pet Medication Market Size by Type
6.2.1 North America OTC Pet Medication Market Size by Type (2017-2022)
6.2.2 North America OTC Pet Medication Market Size by Type (2023-2028)
6.2.3 North America OTC Pet Medication Market Share by Type (2017-2028)
6.3 North America OTC Pet Medication Market Size by Application
6.3.1 North America OTC Pet Medication Market Size by Application (2017-2022)
6.3.2 North America OTC Pet Medication Market Size by Application (2023-2028)
6.3.3 North America OTC Pet Medication Market Share by Application (2017-2028)
6.4 North America OTC Pet Medication Market Size by Country
6.4.1 North America OTC Pet Medication Market Size by Country (2017-2022)
6.4.2 North America OTC Pet Medication Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe OTC Pet Medication Market Size (2017-2028)
7.2 Europe OTC Pet Medication Market Size by Type
7.2.1 Europe OTC Pet Medication Market Size by Type (2017-2022)
7.2.2 Europe OTC Pet Medication Market Size by Type (2023-2028)
7.2.3 Europe OTC Pet Medication Market Share by Type (2017-2028)
7.3 Europe OTC Pet Medication Market Size by Application
7.3.1 Europe OTC Pet Medication Market Size by Application (2017-2022)
7.3.2 Europe OTC Pet Medication Market Size by Application (2023-2028)
7.3.3 Europe OTC Pet Medication Market Share by Application (2017-2028)
7.4 Europe OTC Pet Medication Market Size by Country
7.4.1 Europe OTC Pet Medication Market Size by Country (2017-2022)
7.4.2 Europe OTC Pet Medication Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Pet Medication Market Size (2017-2028)
8.2 Asia-Pacific OTC Pet Medication Market Size by Type
8.2.1 Asia-Pacific OTC Pet Medication Market Size by Type (2017-2022)
8.2.2 Asia-Pacific OTC Pet Medication Market Size by Type (2023-2028)
8.2.3 Asia-Pacific OTC Pet Medication Market Share by Type (2017-2028)
8.3 Asia-Pacific OTC Pet Medication Market Size by Application
8.3.1 Asia-Pacific OTC Pet Medication Market Size by Application (2017-2022)
8.3.2 Asia-Pacific OTC Pet Medication Market Size by Application (2023-2028)
8.3.3 Asia-Pacific OTC Pet Medication Market Share by Application (2017-2028)
8.4 Asia-Pacific OTC Pet Medication Market Size by Region
8.4.1 Asia-Pacific OTC Pet Medication Market Size by Region (2017-2022)
8.4.2 Asia-Pacific OTC Pet Medication Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Pet Medication Market Size (2017-2028)
9.2 Latin America OTC Pet Medication Market Size by Type
9.2.1 Latin America OTC Pet Medication Market Size by Type (2017-2022)
9.2.2 Latin America OTC Pet Medication Market Size by Type (2023-2028)
9.2.3 Latin America OTC Pet Medication Market Share by Type (2017-2028)
9.3 Latin America OTC Pet Medication Market Size by Application
9.3.1 Latin America OTC Pet Medication Market Size by Application (2017-2022)
9.3.2 Latin America OTC Pet Medication Market Size by Application (2023-2028)
9.3.3 Latin America OTC Pet Medication Market Share by Application (2017-2028)
9.4 Latin America OTC Pet Medication Market Size by Country
9.4.1 Latin America OTC Pet Medication Market Size by Country (2017-2022)
9.4.2 Latin America OTC Pet Medication Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Pet Medication Market Size (2017-2028)
10.2 Middle East & Africa OTC Pet Medication Market Size by Type
10.2.1 Middle East & Africa OTC Pet Medication Market Size by Type (2017-2022)
10.2.2 Middle East & Africa OTC Pet Medication Market Size by Type (2023-2028)
10.2.3 Middle East & Africa OTC Pet Medication Market Share by Type (2017-2028)
10.3 Middle East & Africa OTC Pet Medication Market Size by Application
10.3.1 Middle East & Africa OTC Pet Medication Market Size by Application (2017-2022)
10.3.2 Middle East & Africa OTC Pet Medication Market Size by Application (2023-2028)
10.3.3 Middle East & Africa OTC Pet Medication Market Share by Application (2017-2028)
10.4 Middle East & Africa OTC Pet Medication Market Size by Country
10.4.1 Middle East & Africa OTC Pet Medication Market Size by Country (2017-2022)
10.4.2 Middle East & Africa OTC Pet Medication Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer Companion Animal
11.1.1 Bayer Companion Animal Company Details
11.1.2 Bayer Companion Animal Business Overview
11.1.3 Bayer Companion Animal OTC Pet Medication Introduction
11.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2017-2022)
11.1.5 Bayer Companion Animal Recent Developments
11.2 Boehringer Ingelheim Animal Health
11.2.1 Boehringer Ingelheim Animal Health Company Details
11.2.2 Boehringer Ingelheim Animal Health Business Overview
11.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
11.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2017-2022)
11.2.5 Boehringer Ingelheim Animal Health Recent Developments
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale OTC Pet Medication Introduction
11.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2017-2022)
11.3.5 Ceva Sante Animale Recent Developments
11.4 Merck Inc.
11.4.1 Merck Inc. Company Details
11.4.2 Merck Inc. Business Overview
11.4.3 Merck Inc. OTC Pet Medication Introduction
11.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.4.5 Merck Inc. Recent Developments
11.5 Zoetis Inc.
11.5.1 Zoetis Inc. Company Details
11.5.2 Zoetis Inc. Business Overview
11.5.3 Zoetis Inc. OTC Pet Medication Introduction
11.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.5.5 Zoetis Inc. Recent Developments
11.6 Elanco
11.6.1 Elanco Company Details
11.6.2 Elanco Business Overview
11.6.3 Elanco OTC Pet Medication Introduction
11.6.4 Elanco Revenue in OTC Pet Medication Business (2017-2022)
11.6.5 Elanco Recent Developments
11.7 Virbac SA
11.7.1 Virbac SA Company Details
11.7.2 Virbac SA Business Overview
11.7.3 Virbac SA OTC Pet Medication Introduction
11.7.4 Virbac SA Revenue in OTC Pet Medication Business (2017-2022)
11.7.5 Virbac SA Recent Developments
11.8 Vetoquinol SA
11.8.1 Vetoquinol SA Company Details
11.8.2 Vetoquinol SA Business Overview
11.8.3 Vetoquinol SA OTC Pet Medication Introduction
11.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2017-2022)
11.8.5 Vetoquinol SA Recent Developments
11.9 Frontline
11.9.1 Frontline Company Details
11.9.2 Frontline Business Overview
11.9.3 Frontline OTC Pet Medication Introduction
11.9.4 Frontline Revenue in OTC Pet Medication Business (2017-2022)
11.9.5 Frontline Recent Developments
11.10 Zymox
11.10.1 Zymox Company Details
11.10.2 Zymox Business Overview
11.10.3 Zymox OTC Pet Medication Introduction
11.10.4 Zymox Revenue in OTC Pet Medication Business (2017-2022)
11.10.5 Zymox Recent Developments
11.11 ChloraSeb
11.11.1 ChloraSeb Company Details
11.11.2 ChloraSeb Business Overview
11.11.3 ChloraSeb OTC Pet Medication Introduction
11.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2017-2022)
11.11.5 ChloraSeb Recent Developments
11.12 Sulfox
11.12.1 Sulfox Company Details
11.12.2 Sulfox Business Overview
11.12.3 Sulfox OTC Pet Medication Introduction
11.12.4 Sulfox Revenue in OTC Pet Medication Business (2017-2022)
11.12.5 Sulfox Recent Developments
11.13 Adequan
11.13.1 Adequan Company Details
11.13.2 Adequan Business Overview
11.13.3 Adequan OTC Pet Medication Introduction
11.13.4 Adequan Revenue in OTC Pet Medication Business (2017-2022)
11.13.5 Adequan Recent Developments
11.14 Dechra Pharmaceuticals PLC
11.14.1 Dechra Pharmaceuticals PLC Company Details
11.14.2 Dechra Pharmaceuticals PLC Business Overview
11.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
11.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2017-2022)
11.14.5 Dechra Pharmaceuticals PLC Recent Developments
11.15 Nutramax Laboratories, Inc.
11.15.1 Nutramax Laboratories, Inc. Company Details
11.15.2 Nutramax Laboratories, Inc. Business Overview
11.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
11.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2017-2022)
11.15.5 Nutramax Laboratories, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る